Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries.

Research Grants 220 show all


$59.8M
2016

$62.1M
2017

$137.3M
2018

$111.2M
2019

$12.1M
2020

Publications 5,408 show all

  • 118
    Antipsychotic Agents/therapeutic use
  • 96
    Pirenzepine/analogs & derivatives
  • 96
    Schizophrenia/drug therapy
  • 57
    Brain/metabolism
  • 56
    Bipolar Disorder/drug therapy
  • 54
    Enzyme Inhibitors/pharmacology
  • 52
    Piperidines/pharmacology
  • 50
    Drug Design
  • 49
    Depressive Disorder/drug therapy
  • 48
    Attention Deficit Disorder with Hyperactivity/drug therapy

Patents 49,456show all

  • 14,288
    C07D - Heterocyclic compounds
  • 8,557
    A61K - Preparations for medical, dental, or toilet purposes
  • 3,784
    C07C - Acyclic or carbocyclic compounds
  • 3,388
    C07K - Peptides
  • 1,320
    C12N - Microorganisms or enzymes
  • 1,310
    A01N - Preservation of bodies of humans or animals or plants or parts thereof
  • 1,238
    Y02P - Climate change mitigation technologies in the production or processing of goods
  • 1,032
    C07H - Sugars
  • 787
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 697
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium

Clinical Trials 3,859show all

1,097Phase 3858N/A731Phase 2619Phase 1292Phase 4155Other

SEC Filings show all


166
8-K

79
10-Q

24
10-K

Contact Information

Indianapolis, IN
United States